A new cream called difamilast was tested in children with mild-to-moderate eczema. After 4 weeks of treatment, about 45-47% of children using difamilast had clear or almost clear skin, compared to 18% using a placebo cream.
-
A new topical
A new topical
D M W Balak, E Hajdarbegovic
DOI: 10.1111/bjd.20817
Comment
•
251 participants
•
2022
•
0 citations
-
What is this paper about?
-
What populations did the authors study?
251 patients. With mild to moderate eczema. Patients are 2-14 years.
-
What did the authors find?
Analyzing metric: IGA.
Findings show: Invervention leads to 45% (0.3% difamilast), 47% (1% difamilast).
Resulting in: More than twice as many children using difamilast achieved clear or almost clear skin compared to vehicle.
Analyzing metric: EASI-75.
Findings show: Invervention leads to not available.
Resulting in: Significantly better results with difamilast compared to vehicle. -
What conclusions can we draw?
nan
